Guiseppe Campiani

The core research groups represented within NatSynDrugs has been brought together based on international reputation in parasitic infection research. Each group contributes complementary skills to the Platform to facilitate a complete drug development programme. NatSynDrugs aims to realize the combined potential of the core groups involved who have the expertise in:

1- isolation and characterization of new natural products
2- rational design, based on innovative methodologies, of novel synthetic drug candidates
3- managing standard organic chemistry or combichem to synthesize new active chemical entities
4- pharmacological investigation and development of the selected drugable compounds.

Exploration of chemistry and biology of naturally-occurring and synthetic organic molecules with therapeutic potential in neurodegenerative, neuropsychiatric, viral (HIV/HCV) and parasitic (malaria/leishmania) diseases is an important part of my group's research. These interests include target selection and the rational design of innovative drugs, the discovery of new synthetic methodologies and general strategies for synthesis, bioinformatics and the study of important structure-function relationships.